Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults≥ 65 years of age with hypercholesterolemia and with or at moderately …
JAM Foody, WV Brown, F Zieve, AJ Adewale… - The American journal of …, 2010 - Elsevier
Higher than 80% of coronary heart disease-related mortality occurs in patients≥ 65 years of
age. Guidelines recommend low-density lipoprotein (LDL) cholesterol targets for these at …
age. Guidelines recommend low-density lipoprotein (LDL) cholesterol targets for these at …
Ezetimibe added to ongoing statin therapy reduced LDL cholesterol in primary hypercholesterolemia/Commentary
C Gagne, HE Bays, SR Weiss… - ACP Journal Club, 2003 - search.proquest.com
DESIGN Randomized {allocation concealed*}[dagger], blinded (patients, clinicians,{data
collectors, and data analysts}[dagger]),* placebo-controlled trial with 8-week follow-up …
collectors, and data analysts}[dagger]),* placebo-controlled trial with 8-week follow-up …
203: Outcomes Analysis and Utilization Patterns of Ezetimibe/Simvastatin 5/40 mg Daily Dose in a Veterans Affairs Population
MM Gordon, JM Rodgers - Journal of Clinical Lipidology, 2007 - lipidjournal.com
The FDA approved ezetimibe/simvastatin July 23, 2004 and became available as a non-
formulary agent within the Veterans Health Administration (VHA). Local guidelines and a …
formulary agent within the Veterans Health Administration (VHA). Local guidelines and a …
[引用][C] Ezetimibe/simvastatin achieves superior LDL-cholesterol reductions
V Barrios - Inpharma, 2006 - Springer
This double-blind study included 435 patients with hypercholesterolaemia and
atherosclerotic or coronary heart disease, who had elevated LDL-cholesterol levels despite …
atherosclerotic or coronary heart disease, who had elevated LDL-cholesterol levels despite …
Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical …
HS Friedman, S Rajagopalan, JP Barnes… - Clinical Therapeutics, 2011 - Elsevier
Background Randomized studies have demonstrated improved attainment of target low-
density lipoprotein cholesterol (LDL-C) values when ezetimibe is combined with statins for …
density lipoprotein cholesterol (LDL-C) values when ezetimibe is combined with statins for …
Changes in LDL-C Levels and Goal Attainment Associated with Adding Ezetimibe onto Simvastatin, Atorvastatin, and Rosuvastatin Versus Titrating Statins
JAM Foody, P Toth, S Shajjan, D Ramey… - Journal of Clinical …, 2011 - lipidjournal.com
Statin therapy remains the mainstay of lipid-lowering therapy. For those with coronary heart
disease (CHD) and/or CHD risk-equivalent patients on statin monotherapy who still do not …
disease (CHD) and/or CHD risk-equivalent patients on statin monotherapy who still do not …
[PDF][PDF] Ezetimibe plus simvastatin lowered lipid levels more than simvastatin monotherapy in primary hypercholesterolemia
DL Bronson - ACP Journal Club, 2005 - researchgate.net
Setting: 31 sites in the United States and 40 sites in 22 other countries. Patients: 887
patients≥ 18 years of age (mean age 56 y, age range 22 to 81 y, 53% women) with primary …
patients≥ 18 years of age (mean age 56 y, age range 22 to 81 y, 53% women) with primary …
Ezetimibe use and LDL-C goal achievement: a retrospective database analysis of patients with clinical atherosclerotic cardiovascular disease or probable …
BACKGROUND: Ezetimibe is recommended by clinical practice guidelines as a second-line
therapy for lowering low-density lipoprotein cholesterol (LDL-C) levels, but little is known …
therapy for lowering low-density lipoprotein cholesterol (LDL-C) levels, but little is known …